USMCI Members Publications List

 

 

(Members names are in Bold):

 

Aldrich S, Hong C-H, Groves L, Olsen C, Moss J, and Darling TN.

 

Acral lesions in tuberous sclerosis complex:  Insights into pathogenesis. J Am Acad Dermatol.  2010;63:244-51. PMID: 20462663

 

Allard, J., Farley, J., Macri, C., “VAIN " in Section II: Gynecologic Diseases and Conditions in The 5-Minute OB/GYN Clinical Consult. Edited by Paula J. Hillard M.D. Lippincott Williams & Wilkins, 2008; 200.

 

Allard, J., Farley, J., Macri, C., “Ovarian Tumors, Virilizing" in Section II: Gynecologic Diseases and Conditions in The 5-Minute OB/GYN Clinical Consult. Edited by Paula J. Hillard M.D. Lippincott Williams & Wilkins, 2008; 144.

 

Amin A, Benavides LC, Holmes JP, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Storrer CE, Jama YH, Craig D, Stojadinovic A, Ponniah S, Peoples GE. Assessment of pathologic and immunologic patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2007, 48, 1859

 

Amin, A. Stojadinovic, J. P. Holmes, C. E. Storrer, A. M. Smith, Y. H. Jama, D. Craig, S. Ponniah, G. E. Peoples. Assessment of circulating tumor cell (CTC) patterns among disease-free breast cancer patients vaccinated with a preventive HER2/neu E75-peptide vaccine. Journal of Clinical Oncology, 2007, 25, 3059

 

Amin A, Benavides LC, Holmes JP, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Storrer CE, Jama YH, Craig D, Stojadinovic A, Ponniah S, Peoples GE. Pathologic and immunologic patterns among breast cancer (BCa) patienst with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine (E75). Annals of Surgical Oncology., 2007, In Press

 

Amin A, Benavides LC, Holmes JP, Gates JD, Hueman MT, Carmichael MG,

 

Avila NA, Dwyer AJ, Rabel A, Darling T, Hong CH, Moss J. CT of Sclerotic Bone Lesions: Imaging Features Differentiating Tuberous Sclerosis Complex with Lymphangioleiomyomatosis from Sporadic Lymphangioleiomymatosis. Radiology. 2010;254:851-7.

 

Balakathiresan, N., Bhattacharyya, S., Dalgard, C., Gutti, U., Armistead, D., Huang, W., Srivastava, M., Pollard, H.B., and Biswas, R. MicroRNA fingerprints in cystic fibrosis lung epithelial cells: implications for novel therapeutics. Proc. Natl. Acad. Sci., USA. In Press. 2010.

 

Balakathiresan, N.  Gutti, U., Huang, W., Srivastava, M., Pollard, H.B., and Biswas, R. TTP regulates IL-8 mRNA stability in CF lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 296: 1012-8. 2009.

 

Ball WD, Hand AR, Moreira JE, Man YG. Protein D from rat submandibular gland: developmental accumulation and localization. J.Dent.Res. 68:86, 1989

 

Beachkofsky TM, Sapp JC, Biesecker LG, and Darling TN. Progressive overgrowth of the cerebriform connective tissue nevus in patients with Proteus syndrome.  J Am Acad Dermatol. 2010;63:799-804. PMID: 20709429

 

Pulmonary cutaneous metastasis: a case report and review of common cutaneous metastases. Beachkofsky TM, Wisco OJ, Osswald SS, Osswald MB, Hodson DS.Cutis. 2009 Dec;84(6):315-22. Review 

 

Benavides LC, Gates JD, Carmichael MG, Holmes JP, Hueman MT, Mittendorf EA, Patil R, Stojadinovic A, Craig D, Ponniah S, and Peoples GE. Response to a preventive HER2/neu peptide (E75) vaccine based on HER2/neu status. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2008, In Press

 

Benavides LC, Gates JD, Carmichael MG, Patel R, Holmes JP, Stojadinovic A, Ponniah S, Peoples GE. The impact of HER2/neu expression level on response to the E75 Vaccine: From United States Military Cancer Institute Clinical Trials Group Study I-01&I-02. Clin Cancer Res 2009;15:2895-904.

 

Berg PE, Man YG. Increasing BP1 expression correlates with progression and invasion of prostate cancer. Proceedings of American Association for Cancer Research 46: 746, 3171, 2005

 

Berg P, Fu SW, Pinzone JJ, Man YG. The Expression of BP1, a homeotic protein, increases with breast tumor progression. Proc Am Assoc Cancer Res 45: 1159, 2004

 

Berg P, Fu SW, Pinzone JJ, Man YG. BP1 expression correlates with breast tumor aggreesiveness. Platform presentation at the 26^th San Antonio Breast Cancer Symposium (SABCS) at The Late

Breaking News Section and published in the SABCS’ Website, 2003.

 

Berg PE, Rheey J, Bivona L, Man YG, Baxter. Autocrine and paracrine effects of BP1, a       homeotic protein, in breast cancer cells. Proceedings of Department of Defense Breast Cancer Research Program Meeting. P58-7, 391. Baltimore, MD, June 26-29, 2008.

 

Bratthauer GL, Moinfar F, Stamatakos M, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA.        Combined E-Cadherin and high molecular weightt cytokeratin immunoprofile differentiates lobular ductal, and hybrid mammary intraepithelial neoplasias. Human Pathol 33: 620-627, 2002

 

Bratthauer GL, Lininger RA, Man YG, Tavassoli FA. Androgen and estrogen receptor mRNA status in apocrine carcinomas. Dign Mol Pathol 11: 113-118, 2002

 

Breckenridge, L.M., Bruns, G.L., Todd, B.L., & Feuerstein, M. Cognitive limitations associated with Tamoxifen and aromatase inhibitors in employed breast cancer survivor. Psycho-Oncology, 2010. On line .

 

Brown G, Shapeero LG, Weiss BM, Roschewski M. Multiple myeloma with lacrimal gland amyloidosis and sarcoidosis. Am J Hematol. 2010 Jul;85(7):506-9.

 

Brumeanua T, Preda-Paisa A, Stoicaa C, Bonab C, Casaresb S. Differential partitioning and trafficking of GM1 and cholesterol-rich lipid rafts in thymic and splenic CD4 T-cells Molecular Immunology, 2007, 44, 530-540

 

Cai X, Pacheco-Rodriguez G, Fan QY, Haughey M, Samsel L, El-Chemaly S, Wu HP, McCoy JP, Steagall WK, Lin JP, Darling TN, Moss J. Phenotypic Characterization of Disseminated Cells with TSC2 Loss of Heterozygosity in Patients with Lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2010 Jul 16. [Epub ahead of print] PMID: 20639436

 

Cavalli LR, Man YG, Schwartz A, Rone JD, Urban CA, Lima RS, Haddad BR, Berg AE. DNAamplification of the BP1 homeobox gene in breast cancer. Cancer Gen Cytoge 187:19-24, 2008. 

 

Calvio, L., Peugeot, M., Bruns, G. L., Todd, B. L., and Feuerstein, M.  Measures of cognitive function and work in occupationally active breast cancer survivors. Journal of Occupational and Environmental Medicine, 2010, 52(4), 219-227.

 

Calvio L , Feuerstein, M,., and Hansen, JA, Luff, G.  Cognitive limitations in occupationally active brain tumour survivors. Occupational Medicine, 2009, 59, 406-412.

 

Chan, F., Strauser, D., Cardoso, E., Zheng, L. X., Chan, J. Y. C., and Feuerstein, M.  State vocational services and employment in cancer survivors.  Journal of Cancer Survivorship, 2008, 2, 169-178.

 

Carmichael MG, Benavides LC, Holmes JP, Gates JD, Mittendorf EA, Ponniah S, Peoples GE. Results of the first Phase I clinical trial of the HER2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study 1-04. Cancer 2010;116(2):292-301.

 

Carpenter BM, McDaniel TK, Whitmire JM, Gancz H, Guidotti S, Censini S, Merrell DS. Expanding the Helicobacter pylori Genetic Toolbox: Modification of an Endogenous Plasmid for Use as a Transcriptional Reporter and Complementation Vector Applied and Environmental Microbiology, 2007, 73, 4506-14

 

Cavalli L, Man YG, Schwartz A, Haddad B, Berg PE. DNA amplification of the BP1 homeobox gene in breast cancer. (AACR Annual Meeting. April 14-18, 2007. Los Angeles Convention Center, Los Angeles, CA). Proc Am Assoc Cancer Res 48: 401, 2007.

 

Chen MH, Man YG. Promoting effect of croton oil on the induction of lip cancer with Herpes simplex viruses in mice.  Chinese J. of Stomatology 20(6):334-336, 1985

 

Chung LS, Man YG, Lupton GP. WT-1 expression in a spectrum of melanocytic lesions: Implication for differential diagnosis. J Cancer. 1: 120-125, 2010.

 

Contente, S., Yeh, T.J., Friedman, R.M. (2009) Tumor suppressive effect of lysyl oxidase proenzyme. Biochim Biophys Acta 1793  1272-8.

 

D'Amico AV, McLeod DG, Carroll PR, Cullen J, Chen MH. Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality Cancer, 2007, 109, 1290-1295

 

Darcy, K., Brady, W., McBroom, J., Bell, J., Young, R., McGuire, W., Linniolla, I., Hendricks, D., Bonome, T., Farley, J., Associations Between P53 Overexpression and Multiple Measures of Clinical Outcome in High-Risk, Early Stage or Suboptimally-Resected, Advanced Stage Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study, Gynecol Oncol, 2008; 111:487-495.

 

Darling TN, Pacheco-Rodriguez G, Gorio A, Lesma E, Walker C, and Moss J.  Lymphangioleiomyomatosis and TSC2-/- cells.  Lymphat Res Biol. 2010;8:59-69.  PMID: 20235888

 

Dehqanzada ZA, Storrer CF, Hueman MT, Foley RJ, Harris KA, Jama YH, Shriver CD, Ponniah S, Peoples GE. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology. Oncology Reports., 2007, 17, 687-94

 

Devouassoux-Shisheboran M, Schammel DP, Man YG, Tavassoli FA. Fibromatosis of the breast: Age-correlated morphofunctional features of 33 cases. Arch Lab Med Pathol, 124:276-280, 2000

 

Dinauer PA, Brixey CJ, Moncur JT, Fanburg-Smith JC, Murphey MD. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics: a review publication of the Radiological Society of North America, Inc, 2007, 1, 173-87

 

Dubois A, Boren T. Helicobacter pylori is invasive and it may be a facultative intracellular organism Cellular Microbiology, 2007, 9, 1108-16

 

Dubois, A. Intracellular Helicobacter pylori and gastric carcinogenesis: an "old" frontier worth revisiting Gastroenterology, 2007, 132, 1177-80

 

Egland KA, Liu XF, Squires S, Nagata S, Man YG, Bera TK, Onda M, Vincent JJ, Strausberg RL, Lee B, Pastan I. High expression of a novel cytokeratin associated protein in many cancers. Proc Acad Natl Sci USA 103:5929-5934, 2006.

 

Eidelman O, Jozwik C, Huang W, Srivastava M, Rothwell S, Jacobowitz D, Ji X, Zhang X, Guggino W, Wright J, Kiefer J, Olsen C, Adimi N, Mueller G, Pollard HB. Gender Dependence for a Subset of the Low Abundance Signaling Proteome in Human Platelets. Human Genomics and Proteomics. 2010. 2010, 164906.

 

Farley J, Ozbun L, Samimi G, Birrer M. Cell cycle and related protein Disease Markers, 2007, 23, 433-43

 

Farley, J., Ozbun, L., Birrer, M., Genomic Analysis of Epithelial Ovarian Cancer, Cell Research, 2008; 18:538-48.

 

Farley, J., Fuchiuji, S., Darcy, K., Birrer, M., Her-2/Neu Amplification is Not A Predictor of Survival in Advanced Suboptimally Debulked Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study, Gynecol Oncol. 2009: 113: 341-347.

 

Farley JH, Tian, C.,Rose, GS., Brown, C.,Birrer, M.,Maxwell, GL. Race does not impact outcome for advanced ovarian cancer patients treated by standard of cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials". Cancer. 2009: 115:4210-7.

 

Farley, JH., Tian, C. Rose, GS., Brown, C. Birrer, M., Risinger, J., Thigpen, T., Fleming, G.,Gallion, H.,Maxwell, GL.  Chemotherapy Intensity and Toxicity among Black and White Women with Advanced and Recurrent Endometrial Cancer: a Gynecologic Oncology Group Study. Cancer. 2009.

 

Farley, J., “Cell Cycle and Apoptotic Markers” in Prognostic and Predictive Factors in Gynecologic Cancer. Edited by Charles Levenback, Anil Sood, Karen Lu and Robert Coleman, Informa UK Limited, 2007.

 

Farley, J., Ozbun, L., Samimi, G., Birrer, M., “Cell Cycle and Related Proteins” in Biomarkers in Ovarian Disease; Disease Markers. Edited by Birrer, 2007, 23:433-443.

 

Farley, J., Risinger, J., Rose, G., Maxwell, G., Racial Disparities in Blacks with Gynecologic Cancers. Cancer. 2007, Jul 15;110(2):234-43.

 

Farley, J., Ozbun, L., Birrer, M., “Whole-Genome Expression Profiling of Papillary Serous Ovarian Cancer: Activated Pathways, Potential Targets and Noise”; in Pathway Analysis for Drug Discovery. Computational Infrastructure and Applications. Edited by Anton Yurev. Wiley, 2008; 149.

 

Farley, J.H., Birrer, M., “Therapy for the patient with platinum resistant/refractory ovarian cancer should NOT be selected based upon the results of an in vitro extreme drug sensitivity/resistance assay”. Clin Ovarian Cancer. 2009, September 2:26-30.

 

Farley, J.H., Birrer, M.J., “Novel Therapeutic Targets”. Cancer Treat Res, 2009; 149:63-84.

 

Farley, J.H., Birrer, M.J., “Novel Therapeutic Targets” in Ovarian Cancer. Edited by M. Sharon Stack and David Fishman. Springer, 2009; 63.

 

Farley, J.H., Penson, R.T., del Carmen, M.G., Birrer, M, J., Getting personal! The treatment of epithelial ovarian cancer. Clinical Ovarian Cancer; 2009.

 

Farley, J.H., Rose, P. G., Trial Design for Evaluation of Novel Targeted Therapies. Gyncol Oncol. 2010; 116:173-176

 

Farley J, Risinger JI, Rose SG, Maxwell LG. Racial disparities in blacks with gynecologic cancers. Cancer., 2007, 110, 234-43

 

Farley JH, Harlan LC, Clegg LX, Larsen WI, Trimble EL. Patterns of care for cervical cancer patients treated in the U.S. military health care system Journal of Reproductive Medicine, 2007, 52 (11), 1040-5

 

Feuerstein, M. Well being among cancer survivors. Journal of Cancer Survivorship: Research and Practice., 2007, 1, 107

 

Feuerstein, M. Optimizing cancer survivorship. Journal of Cancer Survivorship: Research and Practice., 2007, 1, 1-4

 

Feuerstein, M. Innovations in health care for cancer survivors: Let’s learn from the past. Journal of Cancer Survivorship: Research and Practice., 2007, 1, 177-178

 

Feuerstein, M. Defining cancer survivorship. Journal of Cancer Survivorship: Research and Practice., 2007, 1, 5-7

 

Feuerstein, M. Feuerstein, M. (ed.) Handbook of Cancer Survivorship. Cancer survivorship: Research, practice, and policy. New York: Springer., 2007, 483-494

 

Feuerstein, M. Feuerstein, M. (ed.) Handbook of Cancer Survivorship. Cancer survivorship: A bird's eye view from an insider. New York: Springer., 2007, 3-6

 

Feuerstein, M. Feuerstein, M. (ed.) Handbook of Cancer Survivorship. New York: Springer., 2007

 

Feuerstein, M., Harrington, C. & Hansen, JA. Cancer Symptom Science. Patterns of symptom burden in cancer survivors. Cambridge University Press., In Press, In Press

 

Feuerstein, M., Hansen, J.A., Calvio, L.C., Johnson, L. and Ronquillo, JG. Work productivity in brain tumor survivors. Journal of Occupational and Environmental Medicine., 2007, 49, 803-811

 

Feuerstein, M., Luff, G., and Harrington, C. B. Patterns of workplace disputes in cancer survivors: A population study of ADA claims. Journal of Cancer Survivorship: Research and Practice., 2007, 1, 185-192

 

Feuerstein, M.  Editorial.  Milestone for cancer survivorship research and practice.  Journal of Cancer Survivorship, 2008, 2, 125-127.

 

Feuerstein, M.  Quality health care for cancer survivors: A survivor’s perspective. Journal of CancerSurvivorship: Research and Practice, 2009, 3, 1-3.

 

Feuerstein, M.  The cancer survivorship care plan: Health care in the context of cancer.  Journal of Oncology Practice, 2009, 5, 113-115. 

 

Feuerstein, M.  Cancer survivors need evidence on how to optimize physical function.  Journal of Cancer Survivorship, 2009, 3, 73-77.

 

Feuerstein, M. (Ed). Work and Cancer Survivors. New York: Springer, 2009. (ISBN:978-0-387-72040-1).

 

Feuerstein, M., Todd, B. L., Moskowitz, M., Bruns, G. L., Stoller, M.,  Nassif, T., & Yu, X. Work in cancer survivors: a model for practice and research.  Journal of Cancer Survivorship, 2010, 4(4), 415-437.

 

Feuerstein, M., Bruns, G. L., Pollman, C., & Todd, B. L.  Management of Unexplained Symptoms in Survivors of Cancer.  Journal of Oncology Practice, 2010, 6(6), 308-311.

 

Fowler, CB, Man, Y-G, Zhang, S, O’Leary, TJ, Mason, JT, and Cunningham, RE. “Tissue  microarrays: construction and uses” in Methods in Molecular Biology: Formalin-Fixed Paraffin-embedded tissue protocols (Al-Mulla, F, ed.), Humana Press, New York, NY (in press).

 

Friedman, R.M., Contente, S. (2010) Treatment of hepatitis C infections with interferon: A historical perspective. Hepatitis Research and Treatment doi:10.1155/2010/323926

 

Friedman, R.M., Contente, S. (2009) Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals 2(3):206-216.

 

Fu SW, Schwartz A, Man YG, Pinzone JJ, Bivona L, Stenson H, Simmens S, Teal C, Kim KS, Alani D, Wu W, Vonderhaar BK, Berg PE. BP1 promotes aggressiveness in estrogen receptor positive breast cancer. Submitted.

 

Furusato E, Hidayat A, Man YG, Auerbach A, Furusato B, Rushing EJ. WT1 and Bcl-2 Expression in Melanocytic Lesions of the Conjunctiva: An Immunohistochemical Study of 123 Cases. Arch Ophthalmol 127(8):964-969, 2009. 

 

Furusato B, Koff S, McLeod DG, Sesterhen IA. Sarcoidosis of the prostate Journal of Clinical Pathology, 2007, 60, 325-326

 

Furusato B, Shaheduzzaman S, Petrovics G, Dobi A, Seifert M, Ravindranath L, Nau ME, Werner T, Vahey M, McLeod DG, Srivastava S, Sesterhen IA. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens Prostate Cancer and Prostatic Diseases, 2007

 

Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States. Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Cancer. 2009 Jun 15;115(12):2744-54.

 

Gao C, Furge K, Koeman J, Dykema K, Su Y, Cutler ML, Werts A, Haak P, Vande Woude GF. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations Proceedings from the National Academy of Sciences of the United States of America, 2007, 104, 8995-9000

 

Garayoa M, Man YG, Marinez A, Cuttitta F, Venzon DJ, Mulshine JL Down regulation of hRNP A2/B1 expression in tumor cells under prolonged hypoxia. Am J respir Cell Mol Biol 28: 80-85, 2003

 

Garder K, Man YG, Huang MC, Finkel T, Deng CX. Interplay among BRCA1, SIRT1 and Surviving during BRCA1-associated tumorigenesis. Mol Cell 32(1):11-20, 2008.

 

Gates JD, Benavides LC, Shriver CD, Peoples GE, Stojadinovic A. Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? Journal of Surgical Research., 2008, In Press.

 

Gates JD, Hird LC, H. J. M. E. P. S. Peoples GE Intra-antigenic epitope spreading in HLA-A2+ BrCa patients vaccinated with a MHC Class I peptide (GP2) derived from the transmembrane region of HER2/neu. Annals of Surgical Oncology., 2007, In Press

 

Gates JD, Hird LC, Shriver CD, Peoples GE, Stojadinovic A. Should thyroid ultrasound be performed on all patients undergoing minimally invasive parathyroid surgery (MIPS)? The Journal of Surgical Research, 2007, In Press.

 

Gates JD, Benavides LC, Stojadinovic A, Mittendorf EA, Holmes JP, Carmichael MG, McCall S, Milford AL, Merrill GA, Ponniah S, Peoples GE. Assessment of circulating tumor cells (CTCs) for monitoring immediate and long-term response to primary and booster inoculations with a preventive HER2/neu vaccine in breast cancer patients. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2008, In Press

 

Gates, JD, Carmichael MG, Benavides LC, Holmes JP, Hueman MT, Woll MM, Ioannides CG, Robson CH, McLeod DG, Ponniah S, Peoples GE. Long-term follow-up assessment of a HER2/neu peptide (E75) vaccine for the prevention of recurrence in high-risk prostate cancer patients.  J Am Coll Surg 2009;208:193-201.

 

Gates JD, Benavides LC, Stojadinovic A, Mittendorf EA, Holmes JP, Carmichael MG, McCall S, Milford AL, Merrils GA, Ponniah S, Peoples GE. Monitoring circulating tumor cells in cancer vaccine trials. Hum Vaccin 2008;4389-92.

 

Giam CZ, Kuan-Teh J. HTLV-1 Tax and adult T-cell leukemia Frontiers in bioscience: a journal and virtual library, 2007, 12, 1496-507

 

Ginsburg E, Fu SW, Rheey J, Bivona L, Schwartz A, Man YG, Pinzone JJ, Stevenson H, Simmens S, Teal C, Kim KS, Vonderhaar BK, Berg PE. BP1 promotes aggressiveness of ER positive breast cancer cells.  Submitted.

 

Glasgow CG, Steagall WK, Taveira-DaSilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, Moses M, Darling T, Moss J. Lymphangioleimyomatosis (LAM):  Molecular insight lead to targeted therapies.  Respir Med. 2010; 104:S45-58.  PMID: 20630348

 

Gotay, C.C., Farley, J.H., Kawamoto, C.T., Mearig, A., Adaptation and Quality of Life Among Long-Term Cervical Cancer Survivors in the Military Health Care System, Mil Med, 2008; 173:1035-1041.

 

Halbwedi I, Ullmann R, Kremser ML, Man YG, Isadi-Moud N, Lax S, Denk H, Popper HH, Tavassoli FA, Moinfar F. Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genemic hybridization. Gynecol Oncol 97: 582—587, 2005.

 

Holmes JP, Amin A, Storrer CE, Smith AM, Jama YH, McNeil A, Craig D, Ponniah S, Peoples GE. Clinical and immunologic effects of a HER2/neu (E75) peptide vaccine booster series in previously vaccinated breast cancer patients. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2008, In Press.

 

Holmes JP, Benavides LC, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Murray JL, Amin A, Craig D, von Hofe E, Ponniah S, Peoples GE. Results of the first phase I clinical trial of the novel Ii-key hybrid preventive HER2/neu peptide (AE37) vaccine: United States Military Cancer Institute Clinical Trials Group Study I-03. J Clin Oncol 2008; 26: 3426-3433.

 

Hamilton, C.A., Maxwell, G.L., Chernofsky, M.R., Bernstein, S.A., Farley, J.H., Rose, G.S. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer: A Case Report. Gynecol Oncol. 2008; 111: 530-532.

 

Hamsher C, Smith AM, Dehqanzada ZA, Khoo S, Ponniah S, Peoples GE, Moroni M. Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients. Cancer Immunolgoy, Immunotherapy, 2007, 56, 1711-21

Hansen, J.A., Feuerstein, M., Calvio, L.C., and Olsen, C.  Breast cancer survivors at work. Journal of Occupational and Environmental Medicine, 2008, 50, 777-784.

 

Hansen JA, Feuerstein M, Calvio LC, Olsen C Factors affecting work productivity and cancer survivors. Journal of Occupational and Envirnomental Medicine., In Press.

 

Harless WG, Zier MA, Duncan RC, Hudak JL, McGarvey MD, McLeod DG. An assessment of the virtual conversations method for prostate cancer patient education Urologic Nursing, 2007, 27, 499-506

 

Harrington, C.B., Hansen, J.A, Moskowitz, M., Todd, B., and Feuerstein, M. It’s not over when it’s over: long-term symptoms in cancer survivors – A Systematic review.  International Journal of Psychiatry in Medicine, 2010, 40(2), 163-181.

 

Henson DE, Schwartz AM, Tilara A, Grimley PM, Anderson WF. Population-based analysis of pathologic data: a new approach to the investigation of uterine endometrial and ovarian endometrioid carcinomas Archives of Pathology and Laboratory Medicine, 2007, 131, 1337-42

 

Hird LC, Gates JD, Carmichael MG, Holmes JP, Mittendorf EA, Stojadinovic A, Ponniah S, Peoples GE. Impact of Trastuzumab Treatment on HER2/neu Peptide Vaccination-Preliminary Results for a Combination Immunotherapy. The Journal of Surgical Research, 2007, In Press

 

Holmes JP, Amin A, Hueman M, Khoo S, Sorrer C, Jama Y, Smith AM, Craig D, Stojadinovic A, Sathibalan P, Peoples GE. Breast cancer patients have different levels of endogenous CD8 T cells capable of recognizing a HER2/neu peptide (E75) used as a cancer vaccine in clinical trials. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2007, 48, 1860

 

Holmes JP, Amin A, Storrer CE, Smith AM, Jama YH, McNeil A, Craig D, Ponniah S, Peoples GE. Clinical and immunologic effects of a HER2/neu (E75) peptide vaccine booster in previously vaccinated breast cancer patients. Journal of Clinical Oncology, 2007, 25, 3014

 

Holmes JP, Mittendorf EA, Ponniah S, Peoples GE. Intra-antigenic epitope spreading in HLA-A2+ breast cancer patients vaccinated with a MHC class I peptide (GP2) derived from the transmembrane region of HER2/neu. Journal of Immunotherapy, 2007, In Press.

 

Holmes JP, Gates JD, Benavides LC, Hueman MT, Carmichael MG, Patil R, Craig D, Mittendorf EA, Stojadinovic A, Ponniah S, Peoples GE. Optimal dose and schedule of a HER2/neu (E75) peptide vaccine in disease-free breast cancer patients: From United States Military Cancer Institute Clinical Trials Group Study I-01&I-02. Cancer 2008;113:1666-75.

 

Hong S, Wang LC, Gao X, Kuo YL, Liu B, Merling R, Kung HJ, Shih HM, Giam CZ. Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax The Journal of Biological Chemistry, 2007, 131, 1337-42

 

Hong C-H, Darling TN, Lee C-H. The prevalence of tuberous sclerosis complex in Taiwan: A national population-based study. Neuroepidemiology, 2009; 33:335-341.

 

Hsiao YH, Deng CX, Su YA, Mason JT, Chou MC, Man YG. Aberrant p63 expression in myoepithelium correlating with increased invasiveness in epithelium. European Journal of Cancer  7(4): p34, 2009. 

 

Hsiao YH, Chou MC, Fowler C, Mason JT, Man YG.  Breast cancer heterogeneity: mechanisms, proofs, and implications.  Journal of Cancer 1: 6-13, 2010

 

Hsiao YH, Siddiqui S, Man YG. Dual use of a single Wilms’ tumor 1 immunohistochemistry in evaluation of ovarian tumors: a preliminary study of 20 cases. J Cancer 1:93-97, 2010.

 

Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, Man YG. Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression. Int J Biol Sci 6(5): 428-442, 2010.

 

Hsiao YH, Man YG. Aberrant leukocyte infiltration as a trigger for tumor invasion and metastasis. Accepted for poster presentation at the 2010 AACR meeting.

 

Hsiao YH, Deng CX, Tsai HD, Chou MC, Man YG. Hidden malignant cells within leukocyte  aggregates in normal or hyperplastic tissues of pregnancy-associated breast cancer. Submitted and under revision.

 

Hu LP, Man YG, Chen MH. Effects of different concentrations of serum in culture medium on growth of BRK cells. Chinese J. Anatomy 10(2):134, 1987

 

Hudak JL, McLeod DG, Brassell SA, Gant DA, Shaar S, Hudak RP, Dean RC, McGarvey MD, Tulin SJ, Dozier R. The design and implementation of a multidisciplinary prostate cancer clinic Urologic Nursing, 2007, 27, 491-8

 

Hueman M, Holmes J, Storrer C, Jama Y, Smith A, Khoo S, Stojadinovic A, Ponniah S, Peoples GE. Comparing CD4+CD25+FoxP3+ regulatory T cell levels with ex vivo immune assays and clinical delayed type hypersensitivity responses in a novel HLA Class II HER2/neu peptide vaccine clinical trial in breast cancer patients Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research., 2007, 48, 1861

 

Hueman MT, Holmes JP, Peoples GE. Immune monitoring of CD4+CD25+FoxP3+ regulatory T cells in a novel HLA Class-II HER2/neu peptide vaccine clinical trial in breast cancer patients. Annals of Surgical Oncology., 2007, 14, 26

 

Hueman MT, Stojadinovic A, Storrer CE, Dehqanzada ZA, Gurney JM, Shriver CD, Ponniah S, Peoples GE. Analysis of na?ve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine. Cancer Immunology, Immunotherapy: CII, 2007, 56, 135-46

 

Huppmann M, Shapeero LG.  Complete rupture of the distal biceps tendon. Mil Med. 2010 Jun;175(6):ix-x Ikeda Y, Taveira-DaSilva AM, Pacheco-Rodriguez G, Steagall WK, El-Chemaly S, Gochuico BR, May RM, Hathaway OM, Li S, Wang J-A, Darling TN, Stylianou M, and Moss J.  Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.  Am J Physiol Lung Cell Mol Physiol. 2010 Oct 29. [Epub ahead of print]  PMID: 21036916

 

Jewell E, Levine PH, Man YG, Schwartz A, Veneroso C, Berg PE. Expression of BP1, a homeobox gene, is associated with tumor grade and lymph node status in breast cancer. (AACR  Annual  Meeting. April 14-18, 2007. Los Angeles Convention Center, Los Angeles, CA). Proc Am Assoc Cancer Res 48: 5082, 2007.

 

Jewell EL, Man YG, Schwartz A, Levine PH, Veneroso C, Berg PE.  Expression of BP1, a  homeobox gene, is associated with tumor grade and lymph node status in breast cancer. Submitted and under revision.

 

Joswik, C.J., Pollard, H.B., Srivastava, M., Eidelman, O., Fan, Q.Y., Darling, T., and Zeitlin, P.L. Antibody Microarrays for Cystic Fibrosis. Methods in Molecular Biology, Humana Press, in press, 2010.

 

Kim KH, Dobi A, Shaheduzzaman S, Gao CL, Masuda K, Li H, Drukier A, Gu Y, Srikantan V, Rhim JS, Srivastava S. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase Prostate Cancer and Prostatic Diseases, 2007, 10, 30-8

Kluk BJ, Fu YB, Formolo TA, Zhang L, Hindle AK, Man YG, Siegel RS, Berg PE, Deng CX,

 

Li H, Gu Y, Miki J, Hukku B, McLeod DG, Hei TK, Rhim JS. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alpha-particles International Journal of Oncology, 2007, 31, 537-44

 

Li H, Kapur A, Yang JX, Srivastava S, McLeod DG, Paredes-Guzman JF, Daugsch A, Park YK, Rhim JS. Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin International Journal of Oncology, 2007, 31, 601-6

 

Lindén S, Mahdavi J, Semino-Mora C, Olsen C, Carlstedt I, Borén T, Dubois A. Role of ABO Secretor Status in Mucosal Innate Immunity and H. pylori Infection PLoS Pathogens, 2008, 4, http://pathogens.plosjournals.org/perlserv/?request=get-document\&doi=10.1371/journal.ppat.0040002

 

Lininger RA, Zhuang ZP, Man YG, Park WS, Emmert-Buck M, Tavassoli FA.  Loss of heterozygosity is detected at chromosomes 1p35-36(NB), 3p25(VHL),16p13 (TSC2/PKD1) and17p13(TP53) in microdissected apocrine carcinomas of the breast. Mod Pathol 12:1083-1089, 1999

 

Lininger RA, Zhuang ZP, Man YG, MacGrogan G, Tavassoli FA. LOH at 16p13 is a Novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29:1113-1118, 1998

 

Lininger RA, Fujii H, Man YG, Gabrielson E, Tavassoli FA.  Comparison of loss of heterozygosity  in primary and recurrent carcinoma in situ of the breast.  Mod Pathol 11:1151-1159, 1998

 

Lininger RA, Zhuang ZP, Man YG, Tavassoli FA.  Loss of heterozygosity in microdissected  apocrine carcinomas of the breast and their precursors.  Mod Pathol 10(1):22A, 1997

 

Lininger RA, Zhuang ZP, Man YG, MacGrogan G, Tavassoli FA. LOH in microdissected papillary carcinomas of the breast and their precursors.  Mod Pathol 10 (1):22A, 1997

 

Liu AJ, Man YG, Gardner WA. Prostatic ducts and acini with and without focal disruptions in the basal cell layer have a different gene expression profile: Implications for tumor progression and invasion. American Society for Cell Biology 2007 Annual Meeting, Dec 1-5, Washington DC.

 

Li JH, Man YG.  Dual usages of single wilms’ tumor 1 immunohistochemistry in evaluation of breast tumors.  Cancer Biomarkers 5: 109-116, 2009.

 

Liu AJ, Wei LX, Gardner WA, Man YG. Correlated alterations in prostate basal cell layer and basement membrane. Int J Biol Sci 5: 276-285, 2009.  

 

Liu XF, Bera T, Ha D, Man YG, Lee BK, Pastan I. CAPC expression stimulates malignant phenotypes in vitro. The American Society for Cell Biology 46 Annual Meeting 137: 1688, 2006.

 

Liu ZH, Man YG. Comparison of levels of antibodies to herpes simplex viruses among women in different areas.  J. of Wuhan Medicine 9(4): 264-265, 1985

 

Liu AJ, Man YG, Gardner WA. Correlated alterations in prostate basal cell layer and Basement. Membrane. Mod Pathol 22 (suppl 1): 340a, 2009

 

Ma D, Darling T, Moss J, Lee C-C.  Histologic variants of periungual fibromas in tuberous sclerosis complex.  J Am Acad Dermatol. In Press.

 

Mabille M, Vanel D, Albiter M, Le Cesne A, Bonvalot S, Le Péchoux C, Terrier P, Shapeero LG, Dromain C. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapyrequires different criteria of radiological evaluation.Eur J Radiol. 2009 Feb;69(2):204-8.

 

Man YG. Contribution of intercalated duct cells to normal cellular replacement and regeneration: Assessed by immunocytochemical and autoradiographic methods (Ph.D dissertation). UML Press,1998

Man YG, Chang VY. An innovated tissue embedding method with carbonwax and Paraffin Acta.Academicae Maedicinae of Hubei 6(3):311-312, 1985

 

Man YG, Chen MH. Promoting effect of croton oil on the induction of cervical and vaginal cancers with herpes simplex viruses. Chinese J. of Cell Biology 7(3):110-114, 1985

Man YG, Chen MH. Morphological characteristics of cervical tissues and exfoliated cells of mice infected intravaginally with live and inactivated HSV-2. Virologica Sinica (Chinese National J. of Virology) 2(2): 37-44, 1987

Man YG, Chang VY. An innovated method for sectioning the reproductive organs of mice. Chinese J. of Tumor 7:174, 1987

Man YG. Inhibition of HSV-2 replication in Vero cells by spleen and lymph node cells of mice infected with HSV-2 and treated with interferons. Virologica Sinica 2(2):177-190,1988    

Man YG, Chen MH. Promoting effect of croton oil on the induction of cervical and Vaginal cancers with herpes simplex virus types 1 and 2 in mice. Gyn Oncology 33:27-33, 1989

Man YG, Nauss K. A simple and effective mounting medium for preserving alcohol soluble chromogen.  Histo-logic XXIII (1):15-16, 1993

Man YG, Nauss K. Recovering antigen-antibody reactions from long-term stored tissue sections mounted with our new mounting medium.  Histo-Logic XXIII (1):26-27, 1993

Man YG, Ball WD, Culp AJ, Hand AR, Moreira JE. Persistence of a perinatal cellular phenotype in the ducts of adult glands. J Histochem Cytochem 43(12):1203-1215,1995

Man YG, Marshalleck J. A fast way to prepare paraffin sections for H&E and immunostaining.  Histo-Logic XXV (1):3-5, 1995

Man YG, Tavassoli FA. A simple epitope retrieval method without the use of microwave oven or enzyme digestion. Appl Immunohistochem 4(2):139-141, 1996

Man YG, Zhuang ZP, Bratthauer GL, Bagasra O, Tavassoli FA. Detailed RT-IS PCR protocol for  preserving morphology and confining PCR products in routinely processed paraffin sections.  Cell Vision 3(5):389-396,1996

Man YG, Schammel DP, Tavassoli FA. Detection of telomerase actinity in microdissected breast lesions. Cell Vision 5:84-85, 1998

Man YG, Moinfar F, Bratthauer GL, Tavassoli FA. Five useful approaches for generating more     valid gel images for LOH and clonality analysis with an automated DNA sequencer. Diag Mol Pathol 9:84-90, 2000

Man YG, Bratthauer GL, Ratschek M, Tavassoli FA.  Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (Clinging ductal carcinoma in situ)-A simulator of normal mammary epithelium.  Cancer 88:2072-2081, 2000

Man YG,  Arnould L, Bratthauer GL, Ratschek M, Tavassol FA.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis.  Cancer Res 60: 2562-2566, 2000

Man YG, Harley R, Mason J, Gardner WA. Contributions of leukocytes to tumor invasion and metastasis: the “piggy-back” hypothesis. Cancer Epidem 34(1): 3-6, 2010.

Man YG, Martinez A, Avis IM, Hong SH, Cuttitta F, Venzon DJ, Mulshine JL. Phenotypically different respiratory epithelial cells with hnRNP A2/B1 over-expression display similar genetic    alterations. Am J Respir Cell Mol Biol 23:636-645, 2000

Man YG, Ball WD, Marchetti L, Hand AR. Contributions of intercalated duct cells to normal parenchyma of submandibular glands of adult rats. Anat Rec 263:202-214, 2001

Man YG, Kuhls E, Bratthauer GL, Moinf F, Tavassoli FA.  Multiple use of slab gels in sequencing apparatus for separation of polymerase chain reaction products. Electrophoresis 22:1915-9,2001

Man YG, Moinfar F, Bratthauer GL, Kuhls B, Tavassoli. FA.  An improved method for DNA extraction from paraffin sections. Pathology-Research & Practice. 197:635-642, 2001

Man YG, Ball WD, Hand AR. Contribution of intercalated duct cells to regeneration of the adult SMG.  Accepted for presentation at International Association for Dental Research 78^th Annual meeting, Vancouver,  Canada, March 9-14, 1999;   J Dent Res 78:3173, 1999

 

Man YG, Ball WD. Contribution of interacted duct cells to normal cellular replacement. Accepted for presentation at International Association for Dental Research 78^th Annual Meeting, Vancouver, Canada, March 9-14, 1999; J Dent Res 78:3174, 1999

Man YG, Martinez A, Avis IM, Hong SH, Cuttitta F, Mulshine JL. Similar genetic alterations in pre-malignant and malignant respiratory epithelial cells that express hnRNP. Cancer Res 40: 133, 1999

Man YG, Moinfar F, Shekitka KM, Stamatakos M, Lininger RA, Kuhls E, Bratthauer GL, Tavassoli FA.  Morphologically similar bilateral primary breast tumors display different LOH and CGH profiles in both epithelial and stromal components. Breast Cancer Res Treat 69(3):214, 24, 2001

Man YG, Shekitka KM. Saenger JS, Tai L, Bratthauer GL, Chen PY, Tavassoli FA. Focal loss of estrogen receptor (ER) expression in ER positive ductal intraepithelial neoplasia is associated with disruption of the immediate subjacent myoepithelial cell layer.  Mod Pathol 15(1):42A, 162, 2002

Man YG, Saenger JS, Strauss B, Vang RS, Bratthauer GL, Chen PY, Tavassoli FA.  Focal alterations of p27 expression and subjacent myoepithelial cell layer disruptions are correlated events in ER (-) ductal intraepithelial neoplasia.  Proceedings of Department of Defense Breast Cancer Research Program Meeting. 1: P9,14, 2002, Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel Command. 

 

Man YG, Strauss B, Saenger JS, Tai L, Bratthauer GL, Chen PY, Tavassoli FA. Genetic alterations in ER (-) mammary epithelial cells overlying focally disrupted myoepithelial cell layers. Proceedings of Department of Defense Breast Cancer Research Program Meeting. 1: P9,15, 2002, Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel  Command. 

 

Man YG, Vang RS, Saenger JS, Strauss B, Bratthauer GL, Chen PY, Tavassoli FA. Co-expression of maspin and wilms’ tumor 1 proteins in mammary myoepithelial cells---implication for tumor progression and invasion.  Proceedings of Department of Defense Breast Cancer Research Program Meeting. 1: P9,16, 2002, Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel Command. 

Man YG, Tai L, Barner Ross, Liang CY, Vang RS, Saenger JS, Shekitka KM, Bratthauer GL,   Chen PY, Tavassoli FA.  Focal losses of ER expression in epithelial cells and disruptions of subjacent myoepithelial cell layers are correlated events in ER (+) ductal intraepithelial neoplasia.  Proceedings of Department of Defense Breast Cancer Research Program Meeting. 1: P9,17, 2002,  Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel Command. 

 

Man YG, Burga A, An antigen retrieval protocol that satisfies both immunohistochemical and subsequent molecular assessments. Proceedings of Department of Defense Breast Cancer Research Program Meeting. 1: P9,18, 2002, Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel Command. 

 

Man YG, Shekitka KM, Bratthauer GL, Tavassoli FA. Immunohistochemical and genetic  alterations in mammary epithelial cells overlying focally disrupted myoepithelial cell layers. BreastCancer Res Treat 76 (sup 1): S143, 569, 2002

 

Man YG, Saenger JS, Vang RS, Barner R, Wheeler D, Martinez A, Mulshine JL. Identification of invasive precursor cells in normal and hyperplastic breast tissue. Proceedings of the American Association for Cancer Research. Cancer Res, volume 44: 68, 357, 2003

Man YG, Vang RS, Saenger JS, Strauss BL, Barner R, Wheeler DT, Liang CY, Bratthauer GL,  Mannion C. Development and progression of mammary ductal tumors appear to be mediated by surrounding myoepithelial cells. Mod Pathol 16(1): 39A-40A, 2003

Man YG, Mattu R, Zhang R, Yousefi M, Sang QXA, Shen T. A subset of normal and hyperplastic appearing mammary ductal cells display invasive features. Breast Cancer Res Treat 82  (supplement 1): S141, 2003

 

Man YG, Zhang R, Mattu R, Shen T, Sang QXA. A subset of mammary epithelial cells overlying focally disrupted myoepithelial cell layers shows an unusual immunostaining pattern for proliferation -related proteins. Breast Cancer Res Treat 82 (supplement 1): S163-164, 2003

 

Man YG, Zeng X, Shen T, Vang R, Barner R, Wheeler DT, Vihn T, Liang CY, Strauss BL. Cell clusters overlying focally disrupted myoepithelial cell layers and their adjacent counterparts within the same duct display a different pattern of mRNA expression. Mod Pathol 17 (supplement1): 40-41a, 2004.

 

Man YG, Barner R, Vang R, Wheeler DT, Liang CY, Vihn T, et al. Non-smooth muscle restricted  proteins exclusively or preferentially expressed in mammary myoepithelial cells: a programmed or induced phenomenon? Mod Pathol 17 (supplement 1): 40a, 2004

 

Man YG, Mannion C, Albores-Saaverdra J, Bratthauer GL, Kuhls E, Tavassoli FA. Allelic losses at 3p and 11p are detected in both epithelial and stromal components of cervical small cell neuroendocrine carcinoma.  Appl Immunohistochem Mol Morphology 9:340-345, 2001

Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, Bratthauer GL,Wheeler DT, Liang CL, Vinh TN, Strauss BL. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 5: R231-241, 2003

Man YG, Burgar A. An antigen unmasking protocol that satisfies both immunohistochemical and  subsequent molecular biological assessments. Pathology-Research & Practice 199: 815-825, 2003.

Man YG, Zhang H, Vang R, Strauss B, Zhang L, Gao CL. Direct and repeat uses of tissue sections as templates for liquid phase pcr amplification: applications and implications. Applied Immunohistochem Mol Morph (AIMM) 12: 266-270, 2004.

Man YG, Magrane GG, Lininger RA, Shen T, Kuhls E, Bratthauer BL. Morphologically similar epithelial and stromal cells in primary bilateral breast tumors display different genetic profiles: implications for treatment. AIMM 12:305-314, 2004

 

Man YG, Sang QXA. The significance of focal myoepitehlial cell layer disruptions in breast tumor invasion: a paradigm shift from the “protease-centered” hypothesis. Exp Cell Res 301:103-18,2004

 

Man YG, Shen T, Zhao YG, Sang QX. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events:  A potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detect Prev 29: 161-169, 2005

 

Man YG, Zhang Y, Shen T, Vinh TN, Zeng X, Tauler J, Mulshine JL, Strauss BL. cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors. Breast Cancer Res Treat 89:199-208, 2005.

 

Man YG, Fu SW, Pinzone JJ, Schwartz AM, Simmens SJ, Berg PE. Expression of BP1, a homobox gene, correlates with progression and invasion of mammary ductal Carcinoma.  Breast Cancer Res Treatment 90: 241-247, 2005

Man YG, Shen T, Weisz J, Berg PE, Schwartz AM, Mulshine JL, Sang QXA, Nieburgs HE. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev 29:323-331, 2005.

Man YG, Zhao CQ, Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Therapy 4: 193-204, 2006

Man YG, Nieburgs HE. A subset of cell clusters with malignant features in morphologically normal and hyperplastic breast tissues. Cancer Detect Prev 30 (3): 239-247, 2006.

Man YG, Zhao CQ, Wang J, XL Chen. A subset of prostate basal cells lacks corresponding phenotypic markers.  Pathology-Research & Practice, 202 (9): 651-662, 2006. 

Man YG. Focal degeneration of aged or injured myoepithelial cells and the resultant auto- immunoreactions are trigger factors for breast tumor invasion. Medical Hypotheses 69(6):1340-1357, 2007.

Man YG.  Aberrant leukocyte infiltration: a direct trigger for breast tumor invasion and metastasis. Int J Biol Sci 6(2):129-132, 2010.

Man YG. Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion? Journal of Cancer 2010, 1: 27-31.

Man YG. A seemingly most effective target for early detection and intervention of prostate tumor Invasion. J Cancer  1: 63-69, 2010.

Man YG, Mason J, Harley R, Kim YH, Zhu KM, Gardner WA. Leukocyte–facilitated tumor dissemination: a novel model for tumor cell dissociation and metastasis. J Cell Biochem, Acceptance upon revision

Man YG, Schwartz A, Levine P, Berg PE. BP1, a putative signature marker for inflammatory breast cancer. Cancer Biomarkers 5(1): 9-17, 2009.

Man YG and Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Medical Hypotheses 70: 387-408, 2008.

Man YG. Inhibition of HSV-2 replication in Vero cells by spleen and lymph node cells of mice infected with HSV-2 and treated with interferons.  Antiviral Research 9(2):137, 1988

Man YG, Shen T, Zhao YG, Sang QX. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events:  Implications for basal call layer degradation and tumor invasion. Cancer Detection & Prevention, 2004 Symposium Issue S-51: 15, 2004

 

Man YG, Strauss BL, Berg PE. Increasing BP1 expression correlates with progression and invasion of male breast and prostate tumors. Cancer Detection & Prevention, 2004 Symposium Issue S-95: 149, 2004

Man YG, Berg PE, Barner R, Vinh TN, Wheeler DT, Liang CY, Strauss BL. Morphologically similar normal and hyperplastic mammary ductal cells associated with and without malignant lesions have a different immunohistochemical profile. Cancer Detection & Prevention, 2004 Symposium Issue S-137: 282, 2004

 

Man YG, Yousefi M, Wheeler DT, Barner R, Vang R, Vinh T, Liang CY, Bratthauer GL, Strauss BL. Focal myoepithelial cell layer disruptions and white blood cell infiltration are related events: implications for breast tumor progression and invasion. Proc Am Assoc Cancer Res 45: 2004

 

Man YG, Shen T, Zhao YG, Sang QX. Morphologically comparable prostate acini and ducts with and without a focal basal cell layer disruption have a different cell proliferation rate: Implications for tumor invasion.  FASEB 18(5): A1193, 2004

 

Man YG, Berg PE. Some in situ breast tumor cell clusters exhibit signs of invasion but lack expression of progression and proliferation related biomarkers: seeds for drug resistant tumors. International Conference on Tumor Progression and Therapeutic Resistance. November 8-9, 2004.  Philadelphia, PA. 

 

Man YG, Wang LP. A subset of normal and hyperplastic appearing breast tissues contains cell clusters with malignant features: Implications for tumor progression and invasion.  International Conference on Tumor Progression and Therapeutic Resistance. November 8-9, 2004. Philadelphia, PA. 

 

Man YG, Schwartz A, Levine P, Berg PE. Elevated expression of BP1 in both invasive and metastastic cells of inflammatory breast cancer. Breast Cancer Res Treat (published in 2005)

 

Man YG, Vinh T, Zhao C, Walker A, Barner R. Potential roles of T-lymphocytes and natural killer cells in human myoepithelial cell layer disruptions and tumor invasion. Mod Pathol 18: 42A, 179, 2005

 

Man YG, Schwartz A, Levine P, Berg PE. Elevated expression of BP1 in both invasive and metastastic inflammatory breast cancer. Mod Pathol 18: 300A, 1386, 2005

Man YG, Mannion C, Shen T. Localized basal cell degeneration and resultant immunoreactions are a triggering factor for prostate tumor invasion. FASEB 19: A1517-1518, 860.10, 2005.

 

Man YG. Impacts of focal myoepithelial cell layer disruptions on biologic presentations of overlying epithelial cells: implications for breast tumor progression and invasion. Proceedings of Department of Defense Breast Cancer Research Program Meeting P38-15, 264, 2005.

Man YG. Stromal and vascular invasion of normal and hyperplastic appearing human breast ductal Cells. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-4: 74-75, 2005.

Man YG. Cell clusters overlying focally disrupted myoepithelial cell layers change status of  estrogen receptor expression during tumor invasion. Proceedings of Department of Defense Breast Cancer Research Program Meeting P60-12, 423, 2005

Man YG, Berg PE, Sang QXA. Differential expression of tumor invasion related proteins in cells overlying focally disrupted myoepithelial cell layers and adjacent cells within the same duct. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-5: 75, 2005

Man YG, Berg PE. Expression of BP1, a homobox gene, correlates with progression and invasion of male and uncommon forms of breast tumors. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-6: 75, 2005.

Man YG. A subset of cell clusters overlying focal myoepithelial cell layer disuptions exhibits features of mutated stem cells. Proceedings of Department of Defense Breast Cancer Research Program Meeting P38-12: 263, 2005

Man YG. A subset of female breast tissues contains isolated solid cell massess with unusual morphologic and immunohisochemical features: seeds for drug resistance and recurrence?Proceedings of Department of Defense Breast Cancer Research Program Meeting P38-14: 263-264, 2005

Man YG. CD8 and mast cell tryptase positive cells are preferentially associated with focal myoepithelial cell layer disruptions: implications for breast tumor invasion. Proceedings of Department of Defense Breast Cancer Research Program Meeting P38-13,263, 2005

Man YG. Focal degenerations in surrounding structures and infiltration of immunoreactive cells are a potential trigger for invasion of breast and other epithelium-derived tumors. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-7: 75-76, 2005

Man YG. Genetically different primary bilateral breast tumors show similar signs of potential progression and invasion. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-8: 76, 2005

Man YG. CD8 and mast cell tryptase positive cells are differentially distributed in benign and malignant breast tissues with and without myoepithelial cell layers. Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-9: 76, 2005

Man YG, Chen XL, Garcia FU, Gardner WA. Reduced p63 expression and elevated apoptosis in focally disrupted prostate basal cell layers: Implications for tumor invasion. Accepted for platform presentation at the 2006 USCAP Meeting. Lab Investigation 86:292A; 1358, 2006.

Man YG,  Egland KA, Onda M,  Nagata S, Pastan I. Expression of BPSR correlates with breast and prostate tumor progression and invasion. Proc Am Assoc Cancer Res 47: 2896, 2006

Man YG, Wang J, Cavalli L. Reduced p63 and elevated apoptosis in focally disrupted myoepithelial cell layers: Early signs of breast tumor invasion? Breast Disease 25: 13, 2006.

 

Man YG, Liu XF, Mason J, Prabhakar S, Wang B, Zeng X, Stamatakos, Gardner WA. Prostate tumor cells near and distant from focally disrupted basal cell layers have different gene expression profiles. The American Society for Cell Biology 46 Annual Meeting 143: 1843, 2006.

Man YG, Liu AJ, Gardner WA. Normal appearing prostate acinar and duct clusters with malignant profiles. Mod Pathol 21 (supplement 1): 169A-770, 2008.

Man YG, Liu AJ, Gardner WA. Elevated tenascin expression in stroma near focally disrupted prostate basal cell layers: implications for tumor progression and invasion. Mod Pathol 21 (supplement 1): 169A-771, 2008.

Man YG. Direct physical continuation of normal appearing breast tissues with malignant breast Lesions.  Proceedings of Department of Defense Breast Cancer Research Program Meeting. P71-  13, 479. Baltimore, MD, June 26-29, 2008.

Man YG. Bad seeds produce bad crops: signs of a single step process of breast tumor progression. Proceedings of Department of Defense Breast Cancer Research Program Meeting. P22-4, 150. Baltimore, MD, June 26-29, 2008.

Man YG, Zhang ZY, Wang C, Gao L, Zhang, XC. CAPC expression correlates with breast tumor progression and invasion. Accepted for presentation at 31^st San Antonio Breast Cancer Symposium. San Antonio, TX. Dec 10-14, 2008.

 

Man YG, Mason J, Vinh TN, Zhang SM, Stamatakos MD. Focal myoepithelial cell layer disruptions and basement membrane disappearance are correlated events: implications for breast tumor invasion. FASEB J 21 (5): 554.22, 2007.

 

Man YG. Focal degeneration of aged or injured basal cells and resultant auto-immunoreactions are trigger factors for prostate tumor invasion. Accepted for poster presentation at the Department of Defence Prostate Cancer Research Program Meeting. Septermber 5-8, 2007. Atlanta, GA.

 

Man YG, Gardner WA. Bad seeds produce bad crops: a single step-process of prostate carcinogenesis and Progression. Int J Biol Scien 4: 246-258, 2008.

Man YG. Bad seeds produce bad crops: a single step-process of breast carcinogenesis and Progression. Bioscience Hypotheses. 1:147-155, 2008

 

Mannion C, Park WS, Man YG, Zhuang ZP, Albores-Saavedra, Tavassoli FA. Endocrine tumors  of the uterine cervix: Light microscopic assessment, detection of HPV by non-isotopic in situ hybridization, and analysis for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer 83:1391-  1400, 1998

 

Martinez A, Man YG, Zullo SJ, Cuttitta F.  In situ amplification and detection of nucleic acids. In Beesley JE (ed). Immunocytochemistry & in situ hybridization in the biomedical sciences. Brikhauser Boston, Inc. 156-174, 2001

 

Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, Kirkwood J, Lunsford LD. Gamma Knife Radiosurgery in the Management of Malignant Melanoma Brain Metastases. Neurosurgery, 2007, 60, 471-482

 

McCaffrey TA, Fu SW.  BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer. Int J Biol Sci 2010; 6:512-523.

 

Pseudoaneurysm in the muscular artery of the right gluteal region following a BM harvest. McGregor BA, Ririe DW, Osswald MB. Bone Marrow Transplant. 2009 Aug;44(3):201. Epub 2009 Feb 9.

 

The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.McGregor BA, Brown AW, Osswald MB, Savona MR. Am J Hematol. 2009 Apr;84(4):228-30. Review.

 

McHugh CH, Shapeero LG, et al. Brodie abscess. Mil Med. 2007 Aug;172(8):xii-xiii.

McLeod DG. Editorial Comment on: New Treatment Approaches for Prostate Cancer Based on Peptide Analogues European Urology, 2007

 

Merling R, Chan C, Hong S, Zhang L, Liu M, Kuo YL, Giam CZ. HTLV-1 Tax mutants that do not induce G1 arrest are disabled in activating the anaphase promoting complex Retrovirology, 2007, 4, 35

 

Merrel DS. Environmental stress regulates Shigella virulence: interplay between anerobiosis and iron acquisition Future Microbiology, 2007, 2, 601-4

 

Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens Cancer Research, 2007, 67, 3153-61

Mittendorf EA, Storrer CE, Jama YH, Craig D, Stojadinovic A, Ponniah S, Peoples GE. Assessment of immunologic response and pathologic patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide (E75) vaccine: From United States Military Cancer Institute Clinical Trials Group Study I-01&I-02.  Cancer Immunol Immunoth 2008;57:1817-25.

Mittendorf EA, Holmes JP, Ponniah S, Peoples GE. The E75 HER2/neu peptide vaccine. Cancer Immunology, Immunotherapy, 2008, In Press.

 

Mittendorf EA, Peoples GE. HER2/neu peptide breast cancer vaccines: Current status and future directions. Breast Diseases: A Year Book Quarterly., 2007, 17, 318-20

 

Mittendorf EA, Peoples GE, Singletary ES. Breast Cancer Vaccines: Promise for the future or pipe dream? Cancer, 2007, 110, 1677-86

 

Mittendorf EA, Holmes JP, Murray JL, Peoples GE. CD4+ T cells in antitumor immunity: Utility of an Ii-Key hybrid preventive HER2/neu peptide (AE37) vaccine:  From United States Military Cancer Institute Clinical Trials Group Study I-03.  Expert Opin Biol Ther 2009;9:71-8.

 

Mittendorf EA, Holmes JP, Ponniah S, Peoples GE. The E75 HER2/neu peptide vaccine. Cancer Immunol Immunoth 2008;57:1511-21.

 

Moinfar F, Man YG, Lininger RA, Tavassoli FA. Use of keratin 34BE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-Duct type (Benign and malignant intraductal  proliferations of the breast).  Am J Surg Pathol,  23(9):1048-1058, 1999

 

Moinfar F, Manion C, Man YG, Tavassoli FA. Mammary "comedo-DCIS": Apoptosis, oncosis,  and necrosis. An electron microscopic examination of 8 cases. Ultrastruct Pathol, 24:135-144, 2000

 

Moinfar F, Kremser KL, Man YG, Lax K, Zatloukal K, Tavassoli FA, Denk H. Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the normal-appearing endometrial and myometrial tissues. Gynecol Oncol 95:662-671, 2004

 

Moinfar F, Gogg-Kamerer M, Sommersacher A, Regitnig P, Man YG, Zatloukal K, Denk H, Tavassoli FA. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach. Am J Surg Pathol 29:485-489, 2005.

 

Moinfar F, Man YG, Lininger RA, Tavassoli FA. Use of keratin 34BE12 as an adjunct in the  diagnosis of mammary intraepithelial neoplasia-Duct type (Benign and malignant intraductal proliferations of the breast).  Mod Pathol 11 (1):23A, 117, 1998

 

Moinfar F, Man YG, Bratthauer GL, Tavassoli FA. Genetic abnormaliy in ductal intraepithelial  neoplasis of the flat type (clinging carcinoma in situ) of the breast. Mod Pathol 12:28A, 144, 1999

 

Moinfar F, Kremser KL, Man YG, Lax K, Zatloukal K, Tavassoli FA, Denk H. Allelic imbalances in endometrial stromal neoplasms: A model for genetic alterations in tumor and microenviromental tissues.  Mod Pathol 17 (supplement 1): 208a, 2004

 

Mooney EE, Man YG, Bratthauer GL, Tavassoli FA. Leydig cells in Sertoli-Leydig cell tumors have a reactive rather than a neoplastic molecular profile. Cancer, 86:2312-2319, 1999

 

Monney EE, Man YG, Bratthauer GL, Tavassoli FA. Leydig cells in Sertoli-Leydig cell tumors  have a reactive rather than a neoplastic molecular profile. Mod Pathol 12: 169, 1999

 

Mulshine JL, Hong S, Man YG, Martinez A, Avis I, Montuenga L. Cancer de pulmon: Rastreo sistematizado, nuevos estudios for imagensy prevencion.  Otro Trabajo Publicao: “Review of Lung cancer screening”, Clin Lung Cancer 1:107-135, 2000

 

Nauss K, Man YG. A simple method to rescue immunohistochemical preparations overstained with AEC chromogen. Histo-Logic XXIII (1):32-33, 1993

 

Nauss K, Man YG. Immunohistochemistry - A quick ABC technique using a tissue flotation bath. Histo-Logic XXII (3):321-324, 1992

 

Nelson A, Man YG. Mast cells in high grade lesions of patients co-infected with human papilloma virus and human immunodeficiency virus. Accepted for poster presentation at the 2006 USCAP Annual Meeting. Lab Investigation 86:257A; 1190, 2006.

 

Nelson A, Man YG. HIV and Mast Cells in Human Tissue. Mod Pathol 21 (supplement 1): 288A-1312, 2008.

 

Nelson A, Tuteja A, Man YG. Inflammatory cells and membrane disruption in prostate carcinoma: Do they have a role in tumor invasion. Lab Investigation 87 (Supplement l): 166A, 2007.

 

Nelson AM, Auerbach A, Man YG Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.  Int J Biol Sci 5(6):603-610,2009.

 

Nissan A, Protic M, Bilchik A, Eberhardt J, Peoples GE, Stojadinovic A.  Predictive model of outcome of targeted nodal assessment in colorectal cancer.  Ann Surg 2010;251(2):265-74.

 

Nissan A, Peoples GE, Abu-Wasel B, Adair CF, Prus D, Howard RS, Lenington SG, Fields SI, Freund HR, Peretz T, Burch HB, Shriver CD, Stojadinovic A. Prospective trial evaluating electrical impedence scanning of thyroid nodules prior to thryroidectomy: final results. Annals of Surgery, 2008, In Press

 

Treatment of a population based sample of men diagnosed with testicular cancer in the United States.  Osswald M, Harlan LC, Penson D, Stevens JL, Clegg LX. Urol Oncol. 2009 Nov-Dec;27(6):604-10. Epub 2008 Sep 16.

 

O’Brien JO, Lyons T, Bell KP, Monks J, Lucia S, Wilson RS, Hines L, Man YG, Borges V, Pacheco-Rodriguez G, Steagall WK, C. D. e. a. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis Cancer Research, 2007, 67, 10573-81

 

Parente, L., Uyehara, C., Larsen, W., Whitcomb, B., Farley, J., “Long-Term Impact of the Women’s Health Initiative on HRT, Arch Gynecol Obstet, 2007; 277: 219-224.

 

Patil R, Clifton GT, Holmes JP, Amin A, Carmichael MG, Gates JD, Benavides LC,Jama Y, Mursal M, Zacharia A, Ciano K, Hueman MT, Ponniah S, Peoples GE.  Clinical and immunologic responses of HLA-A3⁺ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial.  JACS 2010;210(2):140-7.

 

Peoples GE, Holmes JP, Hueman MT, Mittendorf EA, Amin A, Khoo S, Dehqanzada ZA, Gurney JM, Woll MM, Ryan GB, Storrer CE, Craig D, Ioannides CG, Ponniah S. Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-01&I-02. Clinical Cancer Research: an official journal of the American Association for Cancer Research., 2008, 14, 797-803

 

Peoples GE, Holmes JP, Hueman MT, Mittendorf EA, Amin A, Khoo S, Dehqanzada ZA,Gurney JM, Woll MM, Ryan GB, Storrer CE, Craig D, Ioannides CG, Ponniah S.  Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-01 &I-02. Clin Cancer Res 2008;14:797-803.

 

Petersen S, Belnap C, Larsen WI, Farley J. Grading of squamous dysplasia in endocervical curettage specimens: The case for conservative management of mild endocervical dysplasia Journal of Reproductive Medicine, 2007, 52, 917-21

 

Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer Cancer, 2007, 110, 1973-8

Richter E, Masuda K, Cook C, Ehrich M, Tadese AY, Li H, Owusu A, Srivastava S, Dobi A. A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer Epigenetics, 2007, 2, 100-9

 

Richter E, Srivastava S, Dobi A. Androgen receptor and prostate cancer Prostate Cancer and Prostatic Diseases, 2007, 10, 114-8

 

Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.  Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB. Med Care. 2008 Oct;46(10):1108-15.

 

Rosner I, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn I, McLeod D, Srivastava S, Petrovics G. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy. Urology, 2007, 70, 1225-9

 

Rupard, Erik. Treatment of Unicentric Castleman Disease With NeoAdjuvant Rituximab. Chest 2010, 138, 1239-1241.

 

Rushing EJ, Olsen C, Man YG. Correlation of p63 immunoreactivity with Tumor Grade in meningiomas. Int J Surg Path 16(1): 38-42, 2008

 

Rushing EJ, Cooper PB, Quezado M, Begnami M, Crespo A, Smirniotopoulos JG, Ecklund J, Olsen C, Santi M. Subependymoma Revisited: Clinicopathological Evaluation of 83 Cases. Journal of Neurooncology., 2007, 3, 297-305

 

Rushing EJ, Liappis A, James D. Smirniotopoulos JD, Smith AB, Henry JM, Man YG, Nelson AM. Immune reconstitution syndrome of the brain Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity.  Accepted for poster presentation at the 2008 Experimental Biology Meeting.  April 5-9, 2008. San Diego, CA

 

Rushing EJ, Man YG. Correlation between p63 immunoreactivity and tumor grade in meningiomas. (Experimental Biology. April 28-May 2, 2007, Washington DC). FASEB J 21 (5): 555.1, 2007.

 

Rushing EJ, Liappis A, James D. Smirniotopoulos JD, Smith AB, Henry JM, Man YG, Nelson AM. Immune reconstitution syndrome of the brain Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity. J Neuropathol Exp Neurol 67(8):819-827,2008.

 

Sahab ZJ, Man YG, Newcomer RG, Sang QXA. Differential protein expression between estrogen receptor positive and negative breast cancer tissues microdissected from the same patient. Clin Exp Metastasis. 2010 Jul 3. [Epub ahead of print]

 

Sahab ZJ, Man YG, Newcomer RG, Sang QXA. Down regulation of superoxide dismutase and rala binding proteins upon the loss of estrogen receptor in human breast ductal carcinoma in situ with microinvasion. Submitted and under revision

 

Sang QXA, Zhao YG, Man YG. Mechanism of human prostate cancer invasion: Basement membrane degradation and basal cell layer disruption. Proceedings of American Association for Cancer Research 46: 1106, 4689, 2005

 

Schaden W, Thiele R, Kölpl C, Pusch M, Nissan A, Attinger CE, Maniscalco-Theberge ME, Peoples GE, Elster EA, Stojadinovic A. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. The Journal of Surgical Research, 2007, 143, 1-12

 

Schwartz AM; Man YG, Rezaei MK, Simmens S, Berg PE. BP1. A homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia (PIN). Mod Pathol 22(1): 1-6, 2009.

 

Schedin P. Alternatively activated macrophages and collagen I remodeling characterize the post-partum involuting mammary gland across species. Am J Pathol 2010 Jan 28. [Epub ahead of print]

 

Shukla V, Coumoul1 X, Lahusen1 T, Wang RH, Xu X, Vassilopoulos A, Xiao C, Lee MH, Man YG, Ouchi M, Ouchi T, Deng CX. BRCA1 Affects Global DNA Methylation through Regulation of DNMT1. Cell Research. Cell Res. 2010 Sep 7. [Epub ahead of print]

 

Shukla V, Coumoul X, Wang RH, Xu XL, Kim HS, Vassilopoulos A, Xiao CY, Lee MH, Lahusen T. Man YG, Ouchi M, Ouchi T, Deng CX. BRCA2 affects global DNA methylation through regulation of DNMT1. Submitted  

 

Weisz J, Shearer DA, Frauenhoffer E, Man YG, McCaffery. Divergent effect of progression of breast cancer from the in situ to the invasive stage on the expression of the retinoic acid biosynthetic enzyme retinaldehyde dehydrogenase 2(RALDH2): Implications for chemoprevention and treatment of breast cancer. Submitted & under revision

 

Schaefer, Richard A., MD MPH, Mil Med. 2006 Jun;171(6):526-9.  The prevalence of admission for sarcoma in the military health system during 2002-2003.

 

Schaefer RA, Crawford RS. Department of Surgery, Uniformed Services University of the Health Sciences and U.S. Military Cancer Institute, Bethesda, MD 20814-4799, USA. PMID: 16808135 [PubMed - indexed for MEDLINE]

 

Schedin P, O,Brien J, Lyons T, Bell P, Man YG, Wilson S, Lucia S, Borges V. Role of mammary gland involvement in promoting metastasis in pregnancy-associated breast cancer (PABC). Proceedings of Department of Defense Breast Cancer Research Program Meeting. P69-2, 464. Baltimore, MD, June 26-29, 2008.

 

Schwartz AM, Man YG, Rezaei MK, Berg PE. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and concordant with prostatic intraepithelial neoplasia. (AACR Annual Meeting. April 14-18, 2007. Los Angeles Convention Center, Los Angeles, CA). Proc Am Assoc Cancer Res 48: 162, 2007.

Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A. Pseudomyxoma Peritonei: An Infectious Disease? Annals of Surgical Oncology, 2008 (in press)

 

Shah MN, Devesa SS, Zhu K, McGlynn KA. Trends in testicular germ cell tumors by ethnic group in the U. S. International Journal of Andrology, 2007, 30, 206-14

 

Shah M, Zhu K, Palmer RC, Wu H. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men. Preventive Medicine, 2007, 44, 459-64

 

Shah M, Zhu K, Palmer RC, Jatoi I, Shriver C, Wu H. Breast, colorectal and skin cancer screening practices and family history of cancer in U.S. women. Journal of Women's Health, 2007, 16, 526-34

 

Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod D, Vahey M, Petrovics G, Dobi A, Srivastava S. Silencing of Lactotransferrin Expression by Methylation in Prostate Cancer Progression Cancer Biology and Therapy, 2007, 6

 

Shapeero LG, Poffyn B, De Visschere PJ, Sys G, Uyttendaele D, Vanel D, Forsyth R, Verstraete KL. Complications of bone tumors after multimodal therapy. Eur J Radiol (in press)

 

Shapeero LG, De Visschere PJ, Verstraete KL, Poffyn B, Forsyth R, Sys G, Uyttendaele D. Post-treatment complications of soft tissue tumours.Eur J Radiol. 2009 Feb;69(2):209-21

 

Shumway NM, Mittendorf EA, Ponniah S, Peoples GE, Murray JL.  Therapeutic breast cancer vaccines: a new immunotherapeutic strategy for early-stage disease. Bio Drugs 2009;23(5):277-87.

 

Siddiqui S, Hsiao YH, Man YG. Dual use of single Wilms’ tumor 1 immunohistochemistry in  evaluation of ovarian tumors: a preliminary study of 20 cases. European Journal of Cancer 7(4):pp35, 2009

 

Sparling JD, Hong CH, Brahim JS, Moss J, Darling TN. Oral findings in 58 adults with tuberous sclerosis complex Journal of the American Academy of Dermatology, 2007, 56, 786-90

 

Sperling L, Hussey S, Wang J, and Darling T.  Cytokeratin 75 expression in central, centrifugal, cicatricial alopecia—new observations in normal and diseased hair follicles.  J. Cutan Pathol.2010;37(2):243-8.

 

Stamatakos M, Vinh TN, Man YG. Elevated expression of tumor aggressiveness and invasiveness-related proteins in cells overlying focally disrupted breast myoepithelial cell layers. Lab Investigation 87 (Supplement l): 309A, 2007.

 

Stany, M., Farley, J., “Complications of Gynecologic Surgery” in Clinics of North America. Edited by Dietrich; Elsevier Saunders Inc. 2008, 88(2):343-349.

 

Srivastava M, Torosyan Y, Raffeld M, Eidelman O, Pollard HB, Bubendorf L. ANXA7 expression represents hormone-relevant tumor suppression in different cancers. International Journal of Cancer, 2007, 121, 2628-36

 

Stewart KMA, Sniezek P, and Darling TN.  Multiple Facial Papules and Macrocephaly. Arch Dermatol. 2010;146:337-42.  PMID: 20231511

 

Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M. HYOU1/Orp150 expression in breast cancer. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research., 2007, 13, BR 231-9

 

Stojadinovic A, Mittendorf EA, Holmes JP, Amin A, Hueman MT, Ponniah S, Peoples GE. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer. Annals of Surgical Oncology., 2007, 14, 3359-68

 

Stojadinovic A, Nissan A, Protic M, Adair CF, Prus D, Usaj S, Howard RS, Radovanovic D, Breberina M, Shriver CD, Grinbaum R, Nelson JM, Brown TA, Freund HR, Potter JF, Peretz T, Peoples GE. Prospective randomized study comparing sentinel lymph node evaluation with standard pathological evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Annals of Surgery, 2007, 245, 846-57

 

Stojadinovic A, Peoples GE, Jurgens JS, Howard RS, Schuyler B, Kwon KH, Henry LR, Shriver CD, Buckenmaier CC.  Prospective randomized study of standard versus pH-adjusted radiocolloid for patients undergoing sentinel lymph node mapping and biopsy for early breast cancer.  Lancet Oncol 2009;10(9):849-54.

 

Stojadinovic A, Nissan A, Protic M, Adair CF, Prus D, Usaj S, Howard RS, Radovanovic D, Breberina M, Shriver CD, Grinbaum R, Nelson JM, Brown TA, Freund HR, Potter JF, Peretz T, Peoples GE.  Prospective randomized study comparing sentinel lymph node evaluation with standard pathological evaluation for the staging of colon carcinoma:results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 2007:245:846-57.

 

Suzuki YJ, Nagase H, Wong CM, Kumar SV, Jain V, Park AM, Day RM. Regulation of Bcl-xL expression in lung vascular smooth muscle. American journal of respiratory cell and molecular biology, 2007, 36, 678-87

 

Tavassoli FA, Man YG, Strauss B, Vang RS, Bratthauer GL, Chen PY.  Morphologically similar stromal cells associated with benign and malignant mammary epithelial tumors display different immunohistochemical and molecular profiles. Proceedings of Department of Defense Breast Cancer Research Program Meeting. 2: P25,18, 2002, Congressionally Directed Medical Research Programs, US Army Medical Research and Materiel Command. 

 

Tavassoli FA, Man YG. Morphofunctional features of intraductal hyperplasia, atypical  hyperplasia, and various grades of intraductal carcinoma. The Breast J 1(3):155-162,1995

 

Tavassoli FA, Purcell CA, Bratthauer GL, Man YG.  Androgen receptor positivity along with loss of bcl-2, ER, and PR expression in apocrine lesions of the breast.  The Breast J. 2: 261-269,1996

 

Tavassoli FA, Man YG. Expression of ER,PR,P53,and Ki67 in nonproliferative, hyperplastic and malignant apocrine lesions of the breast. Modern Pathol 8:135, 1995

 

Tavassoli FA, Purcell CA, Bratthauer GL, Man YG. Emergence of androgen receptor  positivity  along with loss of bcl-2,ER,and PR expression in apocrine lesions of the breast.  Mod Pathol 9:135,1996

 

Tejani A, Yousefi M, Zhao CQ, Man YG. Elevated expression of e-cadherin in cell clusters overlying focally disrupted breast myoepithelial cell layers. Am J Clin Pathol 124 (4): 632-633, 2005.

 

Torosyan Y, Dobi A, Glasman M, Mezhevaya K, Naga S, Huang W, Paweletz C, Leighton X, Pollard HB, Srivastava M. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells. Oncogene. 2010. 29(17):2457-66

 

Torosyan Y., Simakova O., Naga S., Mezhevaya K, Leighton, X., Diaz, J.C., Huang W., Pollard, H.B. and Srivastava, M. Annexin -A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells. Int. J. Cancer, 125: 2528-39., 2009.

 

Vanel D, Albiter M, Shapeero L, Le Cesne, A, Bonvalot S, Le Pechoux C, Terrier P, Petrow P,Caillet H, Dromain C. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesuylate treatment: A prospective study of 54 patients. Eur J Radiology 2005;54:118-23

 

Vinh TN, Wang W, Ni JS, Man YG. Aberrant WT-1 expression in myoepithelial cells of inflammatory breast cancer.  Mod Pathol 22 (suppl 1): 72a, 2009

 

Vinh TN, Tata MY, Man YG. Co-expression of cytoplasmic e-cadherin and c-erbb2: implications for breast tumor invasion. Mod Pathol 21 (supplement 1): 58A-255, 2008.

 

Vinh TN, Tata MY, Man YG. Co-localization of wilms’ tumor 1 with maspin and p63 in mammary myoepithelial cells. Mod Pathol 21 (supplement 1): 58A-256, 2008.

 

Wang W, Man YG. Potential predictive markers for breast tumor aggressiveness and invasiveness. Accepted for oral presentation at the 2009 Annual Conference for Experimental Biology.

 

Wang HL, Man YG. Potential roles of focal basement membrane disruptions and lymphocyte infiltration in colorectal cancer invasion. Am J Clin Pathol 124(4):647, 2005. 

 

Wang RH, Zheng Y, Kim HS, Xu X, Gao L, Luhasen T, Lee MH, Vassilopoulos A, Chen W,  Wang LP, Mannion C, Man YG. Reduction of tumor suppressors and elevation of cytotoxic cells in myoepithelial cell layers of inflammation breast carcinoma: Implication for tumor aggressiveness. Mod Pathol 18: 54A, 238, 2005 

 

Whitman EJ, Brassell SA, Rosner IL, Moncur JT. Merkel cell carcinoma as a solitary metastasis to the testis Journal of Clinical Oncology, 2007, 25, 3785-6

 

Wu H, Zhu K, Jatoi I, Shah M, Shriver CD, Potter J. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer. Breast Cancer Research and Treatment, 2007, 101, 317-24

 

Xia Y, Darling T. Rapidly growing collagenomas in multiple endocrine neoplasia type I. Journal of the American Academy of Dermatology, 2007, 56, 877-80

 

Xu ZL, Wang W, Deng CX, Man YG. Aberrant p63 and WT-1 expression in myoepithelial  cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.  Int J Biol Sci 5(1): 82-96, 2009.

 

Yousefi M, Hashemi, SS, Man YG. Improved double immunohistochemistry for differential diagnosis and early detection of skin tumor invasion. Accepted for presentation at the 2008 Annual Meeting of the American Society for Dermatology.

 

Yousefi M, Hashemi, SS, Man YG. Elevated infiltration of leukocytes and mast cells in melanoma tissues: Implications for tumor development and progression. Accepted for presentation at the 2008 Annual Meeting of the American Society for Dermatology.

 

Yousefi M, Mattu R, Gao C, Man YG.  Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: Implications for tumor progression and invasion.  AIMM 13:30-37, 2005

 

Zhang XC, Wang QY, Gao L, Man YG. Correlated epithelial, myoepithelial, and stromal cell alterations at early stages of breast tumor invasion.  Sixth Annual AACR International Conference: Frontiers in Cancer Prevention Research. December 5-8, 2007, Philadelphia, PA.

 

Zhang XC, Sheng J, Firpo A, Man YG. Ethnicity and differences in mammary myoepithelial cell layers and inflammatory cell infiltration: Implications for differences in tumor development and behavior.  Accepted for oral presentation at the 2008 Experimental Biology Meeting.  April 5-9, 2008. San Diego, CA

 

Zhang R, Man YG, Strauss BL, Vang RS, Saenger JS, Barner R, Wheeler D, Liang CY. A subsetof morphologically identifiable mammary myoepithelial cells lacks expression of corresponding phenotypic markers. Mod Pathol 16(1): 52A, 2003

 

Zhang R, Man YG, Vang RS, Saenger JS, Barner R, Wheeler D, Liang CY,Vinh TN, Bratthauer GL. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res 5: R151-156, 2003

 

Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, Man YG. Atypical expression of e-cadherin in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion. Pathol-Res-Pract 205:375-385, 2009. 

Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, Man YG. Atypical expression of c-erbB2 in cell clusters overlying focally disrupted breast myoepithelial cell layers: a potential sign for increasing cell motility and invasion. Int J Biol Scien 4:259-269, 2008.

 

Zhao YG, Xiao AZ, Park HI, Newcomer RG, Yan M, Man YG, Heffelfinger SC, Sang QX. Endometase in human breast carcinoma, selective activation of progelatinase B and inhibition by tissue inhibitors of metalloproteinases-2 and –4. Cancer Res 64: 590-598, 2004

 

Zhao CQ, Man YG. A subset of morphologically distinct prostate basal cells lacks expression of corresponding phenotypic markers. Am J Clin Pathol 124(4); 658-659, 2005.

 

Zhao C, Barner R, Vinh T, Walker A, Man YG. A subset of normal and hyperplastic appearing  human breast cell clusters exhibited similar immunohistochemical and cytological alterations to cancer cells. Mod Pathol 18: 57A, 250, 2005

 

Zhao C, Mannion C, Man YG. Potential roles of cytotoxic T-lymphocytes and nature killer cells in prostate basal cell layer disruptions and tumor invasion. Mod Pathol 18: 175A, 809, 2005

 

Zhao YG, Xiao AZ, Park HI, Newcomer RG, Yan M, Man YG, Heffelfinger SC, Sang QXA. Endometase in human breast carcinomas, selective activation of progelatinase B and inhibition by tissue inhibitors of metalloproteinases-2 and –4. Breast Cancer Res Treat 82 (suppl 1): S64, 2003.

 

Zhao YG, Xiao AZ, Ni J, Man YG, Sang QX. Expression of matrix metalloproteinase-26 in  multiple human cancer tissues and smooth muscle cells. Chin J Cancer 28(11):1168-75, 2009.

 

Zhu K, Moriarty C, Caplan LS, Levine RS. Cigarette smoking and primary liver cancer: a population-based case-control study in U.S. men Cancer Causes Control, 2007, 18, 315-21

 

Zhuang ZP, Lininger R, Man YG, Albuquerque A, Merino MJ, Tavassoli FA.  Identical clonality  of both components of mammary carcinosarcoma with differential loss of heterozygosity.  Mod  Pathol 10(4):354-362,1997

 

Zorn, K., Gardner, G., Farley, J., Birrer, M., “The Biology of Gynecologic Cancer” in Principles and Practice of Gynecologic Oncology. Edited by Richard Barakat, Maurie Markman, and Marcus Randall. Lippincott William